US Appropriates Nearly All of Covid-19 Drug Remdesivir

By Ben Robinson On June 30, the US government agreed to buy 500,000 doses of remdesivir, a drug produced by the corporation Gilead, which may reduce Covid-19 recovery times. According to the US Department of Health and Human Services, the 500,000 treatments are all of Gilead’s projected production for July, and 90 percent for August and September. Other countries have decried the US’s hoarding as … Continue reading US Appropriates Nearly All of Covid-19 Drug Remdesivir